
U.S. FDA grants interchangeable designation to YUFLYMA® (adalimumab-aaty), Celltrion’s biosimilar to Humira® (adalimumab)...
YUFLYMA® (adalimumab-aaty) is a high-concentration (100mg/mL) and citrate-free formulation of Humira® (adalimumab) biosimilar, that is now interchangeable [1] Interchangeable designation of YUFLYMA® is supported by positive data from the Phase III …